다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP) 뉴스

CRSP

CRISPR Therapeutics (CRSP)

CRISPR Therapeutics AG

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CRSP

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/03	21:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/06/01	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/06/01	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/06/01	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/31	05:26	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/30	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/29	21:00	GlobeNewswire Inc.	CRISPR Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/25	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/24	05:25	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/23	21:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/23	21:00	GlobeNewswire Inc.	CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/09	21:30	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/09	05:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/09	05:00	GlobeNewswire Inc.	CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/05/08	20:00	GlobeNewswire Inc.	CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/04/23	05:30	GlobeNewswire Inc.	CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/04/03	21:00	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/04/01	21:00	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/03/13	21:30	GlobeNewswire Inc.	CRISPR Therapeutics Proposes New Appointment to the Board of Directors	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/22	07:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/22	07:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/21	21:50	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/21	21:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/21	21:30	GlobeNewswire Inc.	CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/17	07:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/16	06:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/15	22:30	GlobeNewswire Inc.	CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/13	22:44	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/13	22:30	GlobeNewswire Inc.	CRISPR Therapeutics Announces $280 Million Registered Direct Offering	NASDAQ:CRSP	CRISPR Therapeutics AG
2024/02/13	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRSP	CRISPR Therapeutics AG

검색 관련기사 보기:NASDAQ:CRSP

1 2 3 4 5 6 7 8 9 10 다음 >>

JP Morgan Chase

American Express

BNP Paribas (QX)

Deutsche Telekom (QX)

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관